WTN News FusionCIO Fusion Symposium Digital Healthcare Conference Blogs WTN Media Advertise

Home Page Subscribe Calendar IT Biotech Health Tech Careers Commentary Capital CIOs Visions More Topics…

Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Third Wave expands distribution of HPV product to Europe

WTN News

January 8, 2008

Madison, Wis. — Third Wave Technologies announced on Tuesday that distributors in Spain, Portugal and Italy have agreed to distribute the firm's human papillomavirus (HPV) screening product, which is used for routine screening for cervical cancer.

Inverness Medical Iberica, the Spanish affiliate of Inverness Medical Innovations, will be the distributor for Spain and Portugal, while four distributors have been secured in Italy.

Third Wave's test, which recently received European CE Marking certificatin, detects 14 types of HPV, which causes most cervical cancer. Worldwide, cervical cancer claims nearly 250,000 lives annually, according to the National Cancer Institute, which estimates nearly 500,000 new cases per year.

Related Stories

• Third Wave completes HPV clinical trial enrollment

• Third Wave secures $25 million line of credit

• Third Wave's revenue up, but costs result in higher loss

Add Your Comment

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.